Spectranetics Corporation today announced that it plans to initiate the EXCITE ISR (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis) clinical trial ...

DENVER--(BUSINESS WIRE)--HEART RHYTHM 2010 – Spectranetics Corporation (NASDAQ:SPNC) today announced it will showcase a new advanced Laser Lead Extraction Simulation system at the Heart Rhythm Society ...

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (Nasdaq: SPNC) today announced that the Food and Drug Administration (FDA) has approved the Company’s premarket approval application ...

"Dr. Kassab's work at Oakwood Hospital further validates the quality-of-life improvements that may be achieved with our CLiRpath excimer laser catheters," said John G. Schulte, president and chief ...

COLORADO SPRINGS, Colo., The Spectranetics Corporation (NASDAQ:SPNC) today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance of its peripheral atherectomy product, the ...

February 5, 2010 (Washington, DC) — Transvenous extraction of implanted-device leads using a laser catheter is nearly always completed successfully and poses little risk of death or other major ...

According to a recent press release, Colorado Springs-based Spectranetics announced that it has received FDA 510(k) clearance for its Turbo-Power™ Laser Atherectomy Catheter, a peripheral atherectomy ...

Shares of Spectranetics ($SPNC), the maker of medical lasers, hit a 6-month low in heavy trading after it reported lower quarterly earnings and trimmed its forecast ...

A few years after he founded Spectranetics Corp. in 1984, the late Robert Golobic told an employee he was afraid that the company's medical laser was only "so-so" and would make it difficult for the ...

Spectranetics Corp., the Colorado Springs-based medical laser manufacturer, said Tuesday it has agreed to pay nearly $8.9 million to settle a pair of legal actions brought by stockholders against the ...

Excimer laser procedure to be tested on more than 350 patients. COLORADO SPRINGS, Colo.--(BUSINESS WIRE)-- Spectranetics Corporation (Nasdaq:SPNC - News) today announced that it plans to initiate the ...